Specific inhibition of epithelial Na+ channels by antisense oligonucleotides for the treatment of Na+ hyperabsorption in cystic fibrosis
✍ Scribed by Katja Sobczak; Andrei Segal; Nadine Bangel-Ruland; Judith Semmler; Willy Van Driessche; Hermann Lindemann; Ralf Heermann; Wolf-Michael Weber
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 335 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1099-498X
- DOI
- 10.1002/jgm.1363
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background
Cystic fibrosis (CF) respiratory epithelia are characterized by a defect Cl^−^ secretion and an increased Na^+^ absorption through epithelial Na^+^ channels (ENaC). The present study aimed to find an effective inhibitor of human ENaC with respect to replacing amiloride therapy for CF patients. Therefore, we developed specific antisense oligonucleotides (AON) that efficiently suppress Na^+^ hyperabsorption by inhibiting the expression of the α‐ENaC subunit.
Methods
We heterologously expressed ENaC in oocytes of Xenopus laevis for mass screening of AON. Additionally, primary cultures of human nasal epithelia were transfected with AON and were used for Ussing chamber experiments, as well as biochemical and fluorescence optical analyses.
Results
Screening of several AON by co‐injection or sequential microinjection of AON and ENaC mRNA in X. laevis oocytes led to a sustained decrease in amiloride‐sensitive current and conductance. Using primary cultures of human nasal epithelia, we show that AON effectively suppress amiloride‐sensitive Na^+^ absorption mediated by ENaC in CF and non‐CF tissues. In western blot experiments, it could be shown that the amount of ENaC protein is effectively reduced after AON transfection.
Conclusions
Our data comprise an initial step towards a preclinical test with AON to reduce Na^+^ hyperabsorption in CF epithelia. Copyright © 2009 John Wiley & Sons, Ltd.